Strategic partnerships Baker is actively forming collaborations with major research and industry players, including CSL Limited, BioCommons, ACvA, and universities, to establish secure data infrastructure and harmonise cohorts. This indicates receptiveness to joint ventures, data sharing agreements, and co-development opportunities that can be leveraged for sponsored research, funded projects, or technology deployments.

Centennial credibility Celebrating 100 years of innovation enhances brand trust and long-term collaboration potential. Use this milestone to position offerings around reliability, proven impact, and scalable solutions for cardiovascular disease, diabetes, and obesity research, appealing to funders, government grants, and philanthropic partnerships.

Digital transformation Recent digital partnerships and a focus on delivering a scalable digital experience suggest openness to IT services, cloud, data management, analytics, and cybersecurity solutions. Opportunities exist for managed services, data platform modernization, and custom software that supports large-scale epidemiological studies and translational research.

Governance and IP As infrastructure collaborations emphasize governance, documentation, training, and IP arrangements, Baker is a suitable customer for solutions around research governance, data stewardship, cloud security, regulatory compliance, and IP protection tools that streamline multi-party collaborations.

Leadership transition readiness Upcoming leadership transition in the centennial year signals a time of strategic realignment and potential procurement cycles for new research tools, collaboration platforms, or clinical research infrastructure. Proactively engage with the Institute to align solutions with evolving governance and strategic priorities.